Showing results (281-290 of 479) with videos related to

Sort By:
Pageof 48
Clinical Biochemistry|July 5, 2005
Apolipoprotein B-100 kinetics and static plasma indices of triglyceride-rich lipoprotein metabolism in overweight menDick C Chan, Gerald F Watts, Theodore W K Ng, et al.
Journal of Atherosclerosis and Thrombosis|December 6, 2023
Association Between Adequate Serum 25(OH)D Levels and Atherogenic Dyslipidemia in Young AdultsChing-Way Chen, Yin-Yi Han, Jing-Shiang Hwang, et al.
Clinical Chemistry|January 15, 2005
Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolismDick C Chan, Gerald F Watts, Theodore W K Ng, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|May 16, 2007
Effect of Smad7 gene overexpression on transforming growth factor beta-induced retinal pigment fibrosis in a proliferative vitreoretinopathy mouse modelShizuya Saika, Osamu Yamanaka, Iku Nishikawa-Ishida, et al.
Journal of Atherosclerosis and Thrombosis|March 6, 2009
Significance of measuring serum concentrations of remnant lipoproteins and apolipoprotein B-48 in fasting periodItsuko Sato, Yuichi Ishikawa, Ai Ishimoto, et al.
Clinical Chemistry|September 29, 2007
Development of a homogeneous assay to measure remnant lipoprotein cholesterolKazuhito Miyauchi, Norihiko Kayahara, Masato Ishigami, et al.
Journal of Atherosclerosis and Thrombosis|September 4, 2024
Pharmacokinetics and Safety of Pemafibrate in Patients with both Dyslipidemia and Severe Renal Impairment: A Phase 4 StudyShun Ishibashi, Hidenori Arai, Koutaro Yokote, et al.
Journal of Atherosclerosis and Thrombosis|December 18, 2024
Effects of Pemafibrate on LDL-C and Related Lipid Markers in Patients with MASLD: A Sub-Analysis of the PEMA-FL StudyRyohei Tanigawa, Atsushi Nakajima, Yuichiro Eguchi, et al.
Pageof 48